Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS)

American Journal of Cardiology

Volumn 90, Issue 7, 2002, Pages 731-736

  Streja, Leanne ^a   Packard, Chris J ^a,b   Shepherd, James ^b   Cobbe, Stuart ^b   Ford, Ian ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG EFFECT; HEART INFARCTION PREVENTION; HUMAN; HYPOCHOLESTEROLEMIA; LIFESTYLE; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

ALCOHOL DRINKING; ANTICHOLESTEREMIC AGENTS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRAVASTATIN; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SCOTLAND; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0036804450     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02599-7     Document Type: Article

References (17)

1. Shepherd J., Ford I., Cobbe S.M., Isles C.G., Lorimer A.R., MacFarlane P.W., McKillop J.H., Packard C.J., for the West of Scotland Coronary Prevention Study Group . Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med. 333:1995;1301-1307.
2. Scandanavian Simvastatin Survival Study Group . Randomised trial of cholesterol lowering in 444 patients with coronary heart disease: the Scandanavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389.
3. Jeenah M., September W., Graadt van Roggen F., de Villiers W., Seftel H., Marais D. Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia. Atherosclerosis. 98:1993;51-58.
4. Ordovas J.M., Lopez-Miranda J., Perez-Jimenez F., Rodriguez C., Park J.S., Cole T., Schaefer E.J. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis. 113:1995;157-166.
5. Von Eckardstein A., Assmann G. Prevention of coronary heart disease by raising high density lipoprotein cholesterol? Curr Opin Lipidol. 11:2000;627-637.
6. 1 levels. Am J Cardiol. 86:2000;221-223.
7. The WOSCOPS Group . Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol. 76:1995;485-491.
8. Lipid Research Clinics Manual of Laboratory Operations. DHEW Publications no. (NIH) 85-268. Washington, DC: Government Printing Office, 1975.
9. Myers G.L., Kimberly M.M., Waymack P.P., Smith S.J., Cooper G.R., Sampson E.J. A reference method laboratory network for cholesterol a model for standardisation and improvement of clinical laboratory measurements . Clin Chem. 46:2000;1762-1772.
10. Morris R., Carstairs V. Which deprivation? A comparison of selected deprivation indexes. J Public Health Med. 13:1991;318-326.
11. Stein E.A., Lane M., Laskaryewski O. Comparison of statins in hypertriglyceridaemia. Am J Cardiol. 81:1998;66B-69B.
12. Packard C.J., Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol. 17:1997;3542-3556.
13. Ericsson S., Eriksson M., Vitols S., Einarsson K., Berglund L., Angelin B. Influence of age on the metabolism of low density lipoproteins in healthy males. J Clin Invest. 87:1991;591-596.
14. Ericsson S., Berglund L., Frostegard J., Einarsson K., Angelin B. The influence of age on low density lipoprotein metabolism effects of cholestyramine treatment in young and old healthy male subjects . J Intern Med. 242:1997;329-337.
15. Hannuksela M., Marcel Y.L., Kesaniemi Y.A., Savolainen M.J. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res. 33:1992;737-744.
16. 1 particles . Arterioscler Thromb Vasc Biol. 20:2000;189-197.
17. Arai T., Yamashita S., Hirano K., Sakai N., Kotani K., Fuyioka S., Noyaki S., Keno Y., Yamane M., Shinohara E., et al. Increased plasma cholesteryl ester transfer protein in obese subjects. Arterioscler Thromb Vasc Biol. 14:1994;1129-1136.